US 11926825
Compounds and methods for reducing ATXN2 expression
granted A61KA61K47/02A61K47/46
Quick answer
US patent 11926825 (Compounds and methods for reducing ATXN2 expression) held by Ionis Pharmaceuticals, Inc. expires Mon Mar 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Mar 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61K, A61K47/02, A61K47/46